Some companies you brand once. Some you engineer over years. Coherence Neuro is the latter.

‍

We've worked alongside Ben, Elise and Nicole since the early days, repositioning the company ahead of a $10M raise, then building the brand and website that gave the science a body, and shaping the narrative and deck that carried them through Seed and again through Series A.

‍

The work underneath all of it was the same: taking therapeutic neuro-technology that manages cancer from within, and making it legible to the rooms that decide whether it gets built. Because frontier companies live in two rooms. The one where the technology is real, and the one where it has to be understood. We built the language that travels between them. Positioning, brand, website narrative, deck design, each one tuned so the story holds its shape whether it's read by an investor, a partner, or a future hire.

‍

To engineer a company's narrative once is a privilege. To do it across rounds, as the science sharpens and the room gets harder to convince, is where the discipline proves itself. We helped Coherence impress investors, attract partnership, and move closer to the future they're building.